Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.
  • The Cook Central Office, 36 South Wabash Avenue, Chicago, will close 02/03/2025.  The new Cook Central Office will open at 115 South LaSalle, Chicago, for in-person service on 02/10/2025.  
  • UPDATE: The State Disbursement Unit (SDU) is processing all payments received. To verify the status of your payment, please log into the SDU parent portal or contact the SDU Customer Service Call Center at 877.225.7077.  For SDU business hours, click here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 16, 2016

Drug Name

Review Type

Class

Manufacturer

Prezcobix
New Drug Initial Review
HIV
Johnson & Johnson
Envarsus XR
New Drug Initial Review
Immunosupressant
Veloxis Pharmaceuticals
Nucala
New Drug Initial Review
 Severe Asthma
Glaxo Smith Kline
Zomacton
New Drug Initial Review
Growth Hormone
Ferring Pharmaceuticals
Veltassa
New Drug Initial Review
Potassium Binder
Relypsa, Inc.
Zepatier
New Drug initial Review
Hepatitis C
Merck
Jadenu
New Drug Appeal
Iron Chelator
Novartis
Triumeq
New Drug Appeal
HIV
ViiV Healthcare
Kitabis
New Drug Appeal
Cystic Fibrosis
Pari Respiratory, Inc.
Invega Trinza
New Drug Appeal
Long Acting Antipsychotic
Johnson & Johnson